Lixte Biotechnology Inc. (LIXT) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Lixte Biotechnology Inc.

    NASDAQ: LIXT · Real-Time Price · USD
    5.03
    0.71 (16.30%)
    At close: Sep 09, 2025, 3:11 PM

    Lixte Biotechnology Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 1.04M 4.2M 5.35M 4.82M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 106.55K n/a 147.02K 150.24K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 -106.55K n/a -970 10.25K
    Total Current Assets
    		 1.04M 4.31M 5.56M 5.09M
    Property-Plant & Equipment
    		 n/a n/a n/a n/a
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 106.55K n/a 147.02K 150.24K
    Total Assets
    		 1.15M 4.31M 5.56M 5.09M
    Account Payables
    		 83.21K 120.51K 183.75K 225.97K
    Deferred Revenue
    		 235.08K 157.1K 165.02K 76.96K
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 n/a n/a -970 n/a
    Total Current Liabilities
    		 318.28K 313.86K 394.79K 302.93K
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Liabilities
    		 318.28K 313.86K 394.79K 302.93K
    Total Debt
    		 n/a n/a n/a n/a
    Common Stock
    		 225.00 225.00 1.66K 1.37K
    Retained Earnings
    		 -52.07M -48.48M -43.39M -37.08M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 827.22K 3.99M 5.17M 4.79M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist